SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	Issuer	View
Apr 29, 2020	SC 13D/A	An amendment to a SC 13D filing	Other	Mirum Pharmaceuticals, Inc.	0001193125-20-126318.pdf 0001193125-20-126318.rtf 0001193125-20-126318.xls View HTML
Mar 23, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-020665.pdf 0001209191-20-020665.rtf 0001209191-20-020665.xls View HTML
Mar 12, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	Mirum Pharmaceuticals, Inc.	0001564590-20-010454.pdf 0001564590-20-010454.rtf 0001564590-20-010454.xls View HTML
Mar 12, 2020	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	Mirum Pharmaceuticals, Inc.	0001564590-20-010471.pdf 0001564590-20-010471.rtf 0001564590-20-010471.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Feb 14, 2020	SC 13G/A	An amendment to the SC 13G filing	Other	Mirum Pharmaceuticals, Inc.	0001172661-20-000737.pdf 0001172661-20-000737.rtf 0001172661-20-000737.xls View HTML
Feb 13, 2020	SC 13G/A	An amendment to the SC 13G filing	Other	Mirum Pharmaceuticals, Inc.	0001193805-20-000192.pdf 0001193805-20-000192.rtf 0001193805-20-000192.xls View HTML
Jan 17, 2020	SC 13D/A	An amendment to a SC 13D filing	Other	Mirum Pharmaceuticals, Inc.	0001193125-20-009903.pdf 0001193125-20-009903.rtf 0001193125-20-009903.xls View HTML
Jan 14, 2020	8-K	Report of unscheduled material events or corporate event	Current Reports	Mirum Pharmaceuticals, Inc.	0001193125-20-007165.pdf 0001193125-20-007165.rtf 0001193125-20-007165.xls View HTML
Jan 14, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-003335.pdf 0001209191-20-003335.rtf View HTML
Jan 14, 2020	4	Statement of changes in beneficial ownership of securities	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-20-003338.pdf 0001209191-20-003338.rtf View HTML

Data provided by Kaleidoscope.